Cedivac-FMD
Cedivac-FMD
Not authorised
- Foot-and-mouth disease virus, serotype O, subtype 1, Inactivated
Product identification
Medicine name:
Cedivac-FMD
Active substance:
- Foot-and-mouth disease virus, serotype O, subtype 1, Inactivated
Target species:
-
Cattle
-
Sheep
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Foot-and-mouth disease virus, serotype O, subtype 1, Inactivated3.00/unit(s)1.00Dose
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Milkno withdrawal periodZero days
-
Meat and offalno withdrawal periodZero days
-
-
Sheep
-
Milkno withdrawal periodZero days
-
Meat and offalno withdrawal periodZero days
-
-
Pig
-
Meat and offalno withdrawal periodZero days
-
-
-
Subcutaneous use
-
Cattle
-
Milkno withdrawal periodZero days
-
Meat and offalno withdrawal periodZero days
-
-
Sheep
-
Milkno withdrawal periodZero days
-
Meat and offalno withdrawal periodZero days
-
-
Pig
-
Meat and offalno withdrawal periodZero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AA04
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France SCS
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 8265
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/08/2022